Back to Search Start Over

Proceedings of the 3rdInternational Conference for Cancer Metabolism and Therapy, October 12–14, 2018, Shanghai, China

Authors :
Xiao, Gary Guishan
Zhang, Zhigang
Lu, Bin
Wang, Hongyang
Fan, Teresa WM
Boros, László G.
Gao, Ping
Pan, Yue
Go, Vay Liang W.
Source :
Pancreas; February 2020, Vol. 49 Issue: 2 p149-157, 9p
Publication Year :
2020

Abstract

The 3rdInternational Conference for Cancer Metabolism and Therapy was successfully held at the South Hospital Conference Center of Shanghai First People's Hospital, nearly 200 international experts from the field of cancer metabolism and therapy and about two thousand local scientists attended the conference. The conference was sponsored by the Yangtze River Delta City Group Hospital Synergistic Development Strategic Alliance, the China Anti-Cancer Association Cancer Metabolism Professional Committee, the Chinese Association for Cancer Metabolism and Therapy under Chinese Medical Doctoral Association-Clinical Precision Medicine, and co-organized by the First People's Hospital Affiliated to Shanghai Jiaotong University, and Shanghai Jiao Tong University School of Basic Medicine Undertake, Translational Medicine Network, Shanghai Anti-Cancer Association Youth Council, Fudan University Affiliated Tumor Hospital, University of California, Los Angeles, Agi Hirshberg Center for Pancreatic Diseases and Hirshberg Foundation for Pancreatic Cancer Research, Dalian University of Technology, New York-Presbyterian, American Cancer Research Association (AACR). The theme of the conference was "Inheritance, Innovation, Excellence, Leading" and its aim is to create a high-end academic exchange platform to discuss new technologies, new methods, and new products in tumor metabolism, tumor immunity, tumor markers and other fields. The conference involves cancer metabolism reprogramming, metabolism and tumor microenvironment, lipid metabolism, non-metabolic function of metabolic enzymes, metabolism and epigenetics, clinical transformation, new technologies for tumor immunotherapy, clinical application of tumor immunotherapy, emerging targeted therapy, PD-1/PD-L1 technology, CAR-T technology, novel tumor protein markers, novel tumor methylation markers, ctDNA, CTC, etc. The meeting ended in a lively discussion among scientists from different levels who truly benefit from the sessions about cancer metabolism and treatment. The next meeting is planned to be held October 2 through October 6, 2019 in Los Angeles, Calif. The meeting venue will be announced accordingly in the meeting web site (www.cmt.org).

Details

Language :
English
ISSN :
08853177 and 15364828
Volume :
49
Issue :
2
Database :
Supplemental Index
Journal :
Pancreas
Publication Type :
Periodical
Accession number :
ejs53121825
Full Text :
https://doi.org/10.1097/MPA.0000000000001482